Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Proefschrift: vooruitgang in diagnostiek invasieve pulmonale aspergillose
feb 2022 | Schimmelinfecties